• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Challenges to Diversity: Recruiting and Retaining Minorities

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-07-01-2001

The word diversity is prevalent in human resources (HR) vocabulary. Companies have established offices of diversity, heightened awareness about it, and opened a dialogue about the issues of workplace heterogeneity. Yet, the results of those efforts are often hard to find in the hallways of corporate America. Although some women are likely to be seen around the conference tables, people of color are conspicuously missing.

Articles in this issue
Overview of the Industry: A World of Opportunities
I Have A Dream: Communicating a Vision Helps Managers Become Leaders
Challenges to Diversity: Recruiting and Retaining Minorities
On the Right Path: Sales Careers in Pharma
Surviving a Merger: HBA Takes a Look
Recent Videos
Related Content
Dr. Claudius A. Hildebrand, member of Spencer Stuart’s global Board and CEO Practice and Leadership Advisory Services and co-author of The Life Cycle of a CEO.

Preparing for the CEO Journey

Michael Wong
February 4th 2025
Article

A Harvard Business School Healthcare Alumni Association Q&A with Spencer Stuart’s Claudius A. Hildebrand.

Roche Appoints Wafaa Mamilli as Chief Digital Technology Officer

Roche Appoints Wafaa Mamilli as Chief Digital Technology Officer

Don Tracy, Associate Editor
January 29th 2025
Article

Effective February 10, 2025, Mamilli will assume global responsibility for the Informatics function for the Roche Group.

Lykos Therapeutics Reshuffles Board of Directors Following FDA Rejection of Midomafetamine Capsules

Lykos Therapeutics Reshuffles Board of Directors Following FDA Rejection of Midomafetamine Capsules

Don Tracy, Associate Editor
January 15th 2025
Article

During the transition period, Lykos will work with a number of shareholders to secure financing for an additional Phase III trial of midomafetamine capsules for post-traumatic stress disorder.

The Recipe for Relief: Overcoming Industry Pain Points

The Recipe for Relief: Overcoming Industry Pain Points

Diane Petrone
December 13th 2024
Article

Why investing in people and training can help drugmakers deal with six pressing challenges in particular in the year ahead.

Gilead Appoints Dietmar Berger as Chief Medical Officer

Gilead Appoints Dietmar Berger as Chief Medical Officer

Don Tracy, Associate Editor
December 13th 2024
Article

Berger joins Gilead with over 25 years of global drug development experience and will oversee the company’s virology, oncology, and inflammation portfolio.

Ankitkumar C. Patel

How to Build and Maintain Relationships with High-Profile Clients

Ankitkumar C. Patel
December 10th 2024
Article

For pharma manufacturers, the primary requirement for working with high-profile clients is matching their organizational level of urgency and organization.